Endocrine Abstracts

Contents

• Prize Lectures and Biographical Notes
• • The European Journal of Endocrinology Prize Lecture
  • • (Aiming at) Deciphering puberty

      ea0026eje1
    • European Journal of Endocrinology Prize Winner

      ea0026eje1biog
  • The Geoffrey Harris Prize Lecture
  • • Ghrelin: a neuroendocrine and/or a metabolic story?

      ea0026gh1
    • Geoffrey Harris Prize winner

      ea0026gh1biog
• Plenary Lectures
• • Disorders of sex development
  • • Disorders of sex development: recent progress

      ea0026pl1
  • Making sense with thyroid hormone
  • • Making sense with thyroid hormone

      ea0026pl2
  • Targets for the management of diabetes in 2011
  • • Targets for the managent of diabetes 2011

      ea0026pl3
  • Gonadotrophin signalling in health and disease
  • • Gonadotrophin signalling in health and disease

      ea0026pl4
  • Endocrine hypertension
  • • Endocrine hypertension

      ea0026pl5
  • Neurosteroids as Regenerative Agents in Brain: Therapeutic Implications for Cognition and Neurodegenerative Disease
  • • Neurosteroids as regenerative agents in brain: therapeutic implications for cognition and neurodegenerative disease

      ea0026pl6
  • Androgen use and misuse: A 2011 view
  • • Androgen use and misuse: a 2011 view

      ea0026pl7
  • Genetics of bone disease
  • • Genetics of bone disease

      ea0026pl8
• Symposia
• • Keep cool, lose weight: brown fat and energy metabolism
  • • Brown adipocytes and energy homeostasis in mice

      ea0026s1.1
    • Physiology of brown adipose tissue in humans

      ea0026s1.2
    • Brown adipose tissue and thermogenesis in lean and obese subjects

      ea0026s1.3
  • Controversies in hyperaldosteronism
  • • Controversies in hyperaldosteronism: whom and how to screen

      ea0026s2.1
    • Adrenal vein sampling

      ea0026s2.2
    • Non-surgical therapy of primary aldosteronism

      ea0026s2.3
  • Molecular mechanisms in neuroendocrine tumours
  • • Somatostatin and dopamine signalling in neuroendocrine tumours

      ea0026s3.1
    • A new truncated variant of somatostatin receptor subtype five, sst5TMD4, is present in pituitary tumours and breast cancer, and impairs the normal response to somatostatin

      ea0026s3.2
    • Lessons from MENX

      ea0026s3.3
  • Subclinical hormone excess
  • • Subclinical adrenal hyperfunction

      ea0026s4.1
    • Normocalcemic primary hyperparathyroidism

      ea0026s4.2
    • Subclinical hyperthyroidism

      ea0026s4.3
  • Novel therapies in type 1 diabetes
  • • Pancreas transplantation

      ea0026s5.1
    • Islet transplantation and regeneration

      ea0026s5.2
    • Stem cells as a treatment option in diabetes

      ea0026s5.3
  • Long term effects of bisphosphonates
  • • The risk of fractures and osteonecrosis

      ea0026s6.1
    • Long term management of osteoporosis

      ea0026s6.2
    • Bone turnover markers in the management of osteoporosis

      ea0026s6.3
  • Novel approaches to in vitro and in vivo imaging
  • • How to visualize G-protein-coupled receptor signaling by FRET

      ea0026s7.1
    • Multiphoton microscopy to visualize cell migration and invasion

      ea0026s7.2
    • Molecular and clinical imaging of adrenal steroidogenesis by iodometomidate

      ea0026s7.3
  • The biological clock and metabolism
  • • Clock genes in human adipose tissue

      ea0026s8.1
    • Circadian clock regulation of glucocorticoid synthesis

      ea0026s8.2
    • Feeding the clock

      ea0026s8.3
  • New endocrine aspects of diabetes mellitus
  • • The incretin system: from discovery to drug development

      ea0026s9.1
    • GLP-1 and the cardiovascular system

      ea0026s9.2
    • GLP-1 biology: beyond the pancreas

      ea0026s9.3
  • New developments in the therapy for NETs
  • • New developments in the therapy for NETs: risk stratification

      ea0026s10.1
    • Peptide receptor targeted radiotherapy

      ea0026s10.2
    • New developments in the therapy for NETs: new drugs including mTOR inhibitors

      ea0026s10.3
  • Genetics of male infertility
  • • Update on genetics in male infertility

      ea0026s11.1
    • Clinical aspects of Klinefelter syndrome in childhood, adolescence and adulthood

      ea0026s11.2
    • Genomics of azoospermia

      ea0026s11.3
  • Novel insights into phosphate metabolism
  • • The maintenance of phosphate homeostasis by FGF23

      ea0026s12.1
    • Genetic disorders of phosphate metabolism

      ea0026s12.2
    • FGF23: marker or predictor of progression in chronic kidney disease

      ea0026s12.3
  • Endocrine response to critical illness
  • • The HPA axis in critical illness

      ea0026s13.1
    • Thyroid hormone metabolism in inflammation and sepsis

      ea0026s13.2
    • Novel insights in endocrine and metabolic changes during critical illness

      ea0026s13.3
  • Female contraception update
  • • Compliance and the risk of pregnancy

      ea0026s14.1
    • New Pills

      ea0026s14.2
    • Abstract unavailable

      ea0026s14.3
  • Emerging therapies in type 2 diabetes
  • • Emerging therapies in type 2 diabetes: bariatric surgery

      ea0026s15.1
    • 11[beta]-Hydroxysteroid dehydrogenase inhibitors for treatment of metabolic syndrome

      ea0026s15.2
    • Future therapies - what is in the pipeline?

      ea0026s15.3
  • TSH Receptor and thyroid disorders
  • • TSH-receptor antibodies

      ea0026s16.1
    • Activating and inactivating TSH receptor mutations

      ea0026s16.2
    • Small molecule TSH receptor agonists and antagonists

      ea0026s16.3
  • Pituitary update
  • • Radiosurgery and radiotherapy of pituitary adenomas

      ea0026s17.1
    • Update on pituitary surgery 2011

      ea0026s17.2
    • Pituitary late effects of radiotherapy for brain tumours

      ea0026s17.3
  • Management of endocrine disease in pregnancy
  • • Type-1 diabetes and pregnancy

      ea0026s18.1
    • Type 2 diabetes and pregnancy

      ea0026s18.2
    • Thyroid autoimmunity in pregnancy

      ea0026s18.3
  • Management of endocrine disease in adolescence
  • • Management of congenital adrenal hyperplasia (CAH) in adolescence

      ea0026s19.1
    • The challenges of managing childhood cancer survivors during adolescence

      ea0026s19.2
    • Management of type 1 diabetes in adolescence

      ea0026s19.3
  • Thyroid function: it is in your genes
  • • Genetics versus environment: what determines thyroid function?

      ea0026s20.1
    • Polymorphic variation in thyroid pathway genes

      ea0026s20.2
    • Genetics of autoimmune thyroid disease

      ea0026s20.3
  • Vitamin D, pregnancy and development
  • • Evolutionary perspective in vitamin D and its receptor VDR

      ea0026s21.1
    • Vitamin D deficiency and supplementation in pregnancy

      ea0026s21.2
    • Maternal vitamin D intake during pregnancy and the risk of type 1 diabetes in the offspring

      ea0026s21.3
  • Non traditional effects of pituitary hormones
  • • Non-thyroidal effects of TSH

      ea0026s22.1
    • Vasopressin and social odour processing in the olfactory system

      ea0026s22.2
    • Prolactin, stem cells and prostate cancer

      ea0026s22.3
  • Optimising thyroid hormone replacement
  • • Is there a place for combined T4 and T3 replacement therapy?

      ea0026s23.1
    • Thyroid dysfunction in the elderly

      ea0026s23.2
    • Failure of thyroxin replacement to suppress TSH: what to do now?

      ea0026s23.3
  • Management of phaechromocytoma
  • • Biochemical screening for phaeochromocytoma using plasma free metanephrines: utility beyond diagnosis

      ea0026s24.1
    • Imaging of pheochromocytoma and paragangliomas

      ea0026s24.2
    • Surgical therapy

      ea0026s24.3
  • GNAS locus: imprinting, animal models and human diseases
  • • Genomic imprinting of the GNAS locus

      ea0026s25.1
    • Epigenetic defects at the GNAS locus and human diseases

      ea0026s25.2
    • Xlas, in vitro functions and possible physiological and pathogenic roles

      ea0026s25.3
  • The role of plasma binding proteins in tissue hormone delivery
  • • Sex hormone-binding globulin: beyond plasma transport

      ea0026s26.1
    • The role of IGFBPs in the tissue-specific actions of IGFs

      ea0026s26.2
    • The role of TTR in tissue delivery of thyroid hormone

      ea0026s26.3
  • Breaking news in adrenal malignancy
  • • European Network for the Study of Adrenal Tumors: Adrenal Cancer Consortium (ENS@T-CANCER)

      ea0026s27.1
    • Transcriptome analysis and microRNAs in adrenal tumours

      ea0026s27.2
    • Management of adrenocorticol carcinoma: what have we learnt from recent trials?

      ea0026s27.3
  • Polycystic ovary syndrome: classification, genetics and therapy
  • • Phenotypes and enviromental factors in PCOS

      ea0026s28.1
    • Genetics

      ea0026s28.2
    • PCOS: treatment of infertility and prediction of success

      ea0026s28.3
• JOE/JME Prize Presentation
• • The central nervous system and the control of adipocyte and hepatic metabolism
  • • The central nervous system and the control of adipocyte and hepatic metabolism

      ea0026jp1
• Meet the Expert Sessions
• • (1)
  • • Pros and cons of bariatric surgery

      ea0026mte1
    • Primary hyperaldosteronism

      ea0026mte2
    • Management difficulties in recurrences and metastases of thyroid cancer

      ea0026mte3
    • Mass spectrometry in the measurement of hormones

      ea0026mte4
    • Abstract unavailable

      ea0026mte5
    • Difficult adrenal cases

      ea0026mte6
    • When to instigate insulin therapy in DM2

      ea0026mte7
    • Pathogenesis and management of primary ovarian failure

      ea0026mte8
    • Pleiotropic effects of vitamin D

      ea0026mte9
    • Biomarkers of thyroid malignancy

      ea0026mte10
    • Prolactin and breast tumorogesis: a novel concept of prolactin biology

      ea0026mte11
    • Treatment strategies for obesity

      ea0026mte12
    • Hyponatraemia

      ea0026mte13
    • Graves' ophthalmopathy (GO)

      ea0026mte14
    • Cushing's

      ea0026mte15
    • Endocrine care in HIV-infected patients

      ea0026mte16
    • Management of phaeochromocytomas and paragangiolomas

      ea0026mte17
    • Weird thyroid function tests

      ea0026mte18
    • Management of primary hyperparathyroidism

      ea0026mte19
    • Glucocorticoid replacement therapy

      ea0026mte20
    • To whom to offer genetic analysis in patients with pituitary adenoma

      ea0026mte21
    • Diabetes and the genome: any use for our patients?

      ea0026mte22
    • Transgenic animals in endocrinology

      ea0026mte23
    • Stem cell biology

      ea0026mte24
• Oral Communications
• • Thyroid/Adrenal
  • • Maternal first trimester thyroid hormone levels within the normal range affect birth weight: results from a large population-based cohort study

      ea0026oc1.1
    • Smoking habits and early pregnancy thyroid hormone and antibody levels

      ea0026oc1.2
    • Maternal thyroid dysfunction during pregnancy and thyroid function of the offspring at the age of 16 years

      ea0026oc1.3
    • Results of 1,Ortho-1,para'-dichloro-diphenyl-dichloroethane (O,p'DDD) treatment in 76 patients with Cushing's disease

      ea0026oc1.4
    • Adrenal crisis and general morbidity in chronic adrenal insufficiency prospectively assessed in 472 patients

      ea0026oc1.5
    • Increased risk of infections in patients with Addison's disease

      ea0026oc1.6
  • Neuroendocrinology
  • • Etoposide, doxorubicin, cisplatin, and mitotane versus streptozotocin and mitotane in adrenocortical carcinoma: preliminary results from the first international phase III trial: the FIRM-ACT study

      ea0026oc2.1
    • Gonadotropin responses to kisspeptin are modulated by changes in aminoacidergic and neuropeptidergic neurotransmission: studies in peripubertal male rats

      ea0026oc2.2
    • Distribution of serotonin transporters in the human hypothalamus

      ea0026oc2.3
    • Genetic and molecular cytogenetic investigations in Turner syndrome patients with spontaneous pubertal development

      ea0026oc2.4
    • Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinemia

      ea0026oc2.5
    • The spectrum and causes of gonadal dysfunction in adolescents and adults with Prader--Willi syndrome (PWS)

      ea0026oc2.6
  • Bone/Reproduction
  • • Mild hyponatremia as a risk factor for fractures: the Rotterdam study

      ea0026oc3.1
    • Changes in serum magnesium levels during cinacalcet therapy for primary hyperparathyroidism

      ea0026oc3.2
    • Evolution of neurobehavioral and cognitive symptoms in patients with primary hyperparathyroidism belonging to the Swiss primary hyperparathyroidism cohort

      ea0026oc3.3
    • Low doses of bisphenol A promote human seminoma cell proliferation in vitro by activating PKA and PKG via the non classical membrane G protein-coupled estrogen receptor (GPER)

      ea0026oc3.4
    • IGF1 promotes survival of mast cells and regulates their number in the developing mammary gland

      ea0026oc3.5
    • Materno-fetal cardiovascular complications in Turner syndrome after oocyte donation: a French multicenter retrospective study

      ea0026oc3.6
  • Diabetes/Thyroid
  • • Obestatin improves in vitro generation of novel insulin and glucagon secreting islet-like cell clusters from islet-derived non differentiated cells

      ea0026oc4.1
    • Hepatic insulin resistance in rats on free-choice high-fat diets

      ea0026oc4.2
    • Association of genetic polymorphisms in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein with the metformin intolerance and weight lowering in patients of type 2 diabetes

      ea0026oc4.3
    • HLA-G polymorphism and papillary thyroid cancer histological aggressiveness

      ea0026oc4.4
    • Comparison of four strategies of radioiodine ablation in patients with thyroid cancer with low-risk of recurrence: the randomized, prospective ESTIMABL study

      ea0026oc4.5
    • No causal relationship between Yersinia enterocolitica infection and autoimmune thyroid disease: evidence from a prospective study

      ea0026oc4.6
  • Hormone metabolism and action
  • • HDL receptor SR-BI dysfunction is associated with a diminished adrenal glucocorticoid output in mice and man

      ea0026oc5.1
    • Site specific overexpression of urocortin 2 results in modulation of steroidogenesis in vivo

      ea0026oc5.2
    • Identification of melanocortin 2 receptor structures responsible for specific membrane expression and ACTH binding specificity

      ea0026oc5.3
    • Adrenal melanocortin 2 receptor associated protein (MRAP) expression is regulated by ACTH and angiotensin II, whereas MRAP2 levels are associated with ACTH responsiveness

      ea0026oc5.4
    • The effect of MCT8 on the biological activity of T3

      ea0026oc5.5
    • A novel non-radioactive assay detects PTU-sensitive enzymatic deiodination of natural and synthetic iodinated compounds

      ea0026oc5.6
• Poster Presentations
• • Adrenal cortex
  • • Pituitary-adrenal axis in male rats after exposure to high ambient temperature

      ea0026p1
    • Relatival adrenal failure in trauma patient: therapy approach

      ea0026p2
    • MicroRNAs as endogenous modulators of glucocorticoid receptor expression in the adrenal gland after ACTH stimulation test

      ea0026p3
    • Effects and kinetics of mitotane in in vitro and in vivo models of adrenocortical carcinoma

      ea0026p4
    • The utility of FDG-PET CT in differentiating malignant from benign adrenal lesions

      ea0026p5
    • CT imaging in patients with adrenal incidentaloma

      ea0026p6
    • Self-management in patients with adrenal insufficiency

      ea0026p7
    • Validation of the disease-specific quality of life questionnaire AddiQoL in European Addison patients

      ea0026p8
    • Diagnostic value of urinary steroid profiling for detecting adrenocortical carcinoma

      ea0026p9
    • Surgery in adrenocortical carcinoma; importance of national cooperation and centralized surgery

      ea0026p10
    • Arthritis after removal of adrenal adenoma in Cushing's syndrome

      ea0026p11
    • Influence of drospirenone on renin-angiotensin-aldosterone system evaluation

      ea0026p12
    • Redefinition of age and sex specific reference intervals of eight serum steroids by liquid chromatography: tandem mass spectrometry (LC-MS/MS)

      ea0026p13
    • Autosomal recessive pseudohypoaldosteronism: a rare cause of life-threatening electrolyte imbalance

      ea0026p14
    • Interstitial cortisol levels obtained by adipose tissue microdialysis in mechanically ventilated septic patients: correlations with total and free serum cortisol

      ea0026p15
    • Potential role of mast cells in the physiopathology of aldosterone-producing adenoma

      ea0026p16
    • Abstract unavailable

      ea0026p17
    • Bilateral primary adrenocortical carcinomas developing severe muscle weakness

      ea0026p18
    • Polymorphisms of the HSD11B1 gene as phenotype modifiers in women with hypercortisolism

      ea0026p19
    • Clinical presentation of Cushing's syndrome in a large series from the European Registry on Cushing's syndrome (ERCUSYN)

      ea0026p20
    • Mortality and morbidity in Cushing's syndrome: a single centre experience

      ea0026p21
    • Cardiac structure and function in patients with adrenal incidentaloma with and without subclinical Cushing's syndrome

      ea0026p22
    • Multicenter study on the prevalence of sexual symptoms in men affected by Addison disease

      ea0026p23
    • Hormones failing the heart

      ea0026p24
    • Cushing's syndrome in pregnancy due to LH/hCG receptor positive adrenocortical carcinoma: case report

      ea0026p25
    • Predictive value of acute cortisol response to cabergoline administration on the responsiveness of cortisol secretion to short and long term treatment with cabergoline

      ea0026p26
    • Do mitotane levels impact on the outcome of patients treated adjuvantly following radical resection of adrenocortical cancer (ACC)?

      ea0026p27
    • Impact of long-term cabergoline treatment on clinical, metabolic and hormonal features in patients with Cushing's syndrome

      ea0026p28
    • TP53 and adrenocortical cancer: analysis of germline mutations and polymorphic changes in 140 patients

      ea0026p29
    • Is plasma mitotane level >30 mg/l a serious adverse event in patients with adrenocortical carcinoma (ACC)?: a retrospective analysis of the French COMETE network

      ea0026p30
    • 18-Oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism

      ea0026p31
    • Mission study: an international observational study on the mortality in Cushing's syndrome

      ea0026p32
    • Response of human adrenocortical carcinoma cell lines to cytostatic drugs and mitotane and the role of the multidrug resistance pump MDR1

      ea0026p33
    • Norwegian patients with congenital adrenal hyperplasia have a high frequency of adrenal myelolipomas and adrenal hypoplasia, and testicular adrenal rest tumours was only detected in men with the saltwasting form

      ea0026p34
    • Presence of liver X receptors alfa (LXRalfa) and beta (LXRbeta) in cortisol-secreting adrenal adenomas

      ea0026p35
    • Radiosurgery with application of protone beam in patients with Cushing's disease: a hormonal monitoring of the long-term results

      ea0026p36
    • Thoracic and gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) and the ectopic ACTH syndrome (EAS)

      ea0026p37
    • The role of insulin tolerance test (ITT) and ACTH/cortisol ratio in chronic fatigue patients

      ea0026p38
    • Quality of life in patients in long-term remission of Cushing's syndrome is impaired, regardless of etiology, treatment strategy or remaining hormonal deficiencies

      ea0026p39
    • Sunitinib in refractory adrenocortical carcinoma: results of a phase II trial

      ea0026p40
    • Adrenal insufficiency: etiopathogeny and diagnostic aspects

      ea0026p41
  • Endocrine disruptors
  • • Evaluation of the effect of L-thyroxine therapy on endothelial functions in patients with subclinical hypothyroidism

      ea0026p42
    • Evaluation of the incidence of disorders glycoregulation in some diseases endocrine

      ea0026p43
    • Real-idiopathic precocious puberty: therapeutic approach

      ea0026p44
    • Haematological and reproductive toxicity of nicotine and protective role of green tea extract in male rats

      ea0026p45
    • Bone remodeling parameters and bone mass in patients with schizophrenia treated with long-acting injectable risperidone

      ea0026p46
    • Prognostic factors of non-alcoholic steatohepatitis associated with obesity

      ea0026p47
    • The role of progestins in the interplay of estradiol and genistein: influences on the steroid hormone receptor expression patterns in distinct uterine compartments

      ea0026p48
    • Serum procalcitonin measurement as a marker of sepsis

      ea0026p49
    • Parathyroid adenoma screening efficacies of different imaging tools and factors affecting the success rates

      ea0026p50
    • In vitro testing for goitrogenic potential of glucosinolate extracts

      ea0026p51
    • Phytoestrogen genistein causes downregulation of oestrogen receptor [alpha] in uterus of female Sprague Dawley rats

      ea0026p52
  • Endocrine tumours and neoplasia
  • • Insulinoma in crete: a rare tumor?

      ea0026p53
    • Frequency, localisation of unusual metastases of medullary thyroid cancer and impact on survival: an observational study in 102 patients

      ea0026p54
    • Diagnosis of post-surgical recurrence in patients with malignant insulinoma

      ea0026p55
    • The T-box transcription factor TBX1, the candidate gene of 22q11.2 microdeletion/DiGeorge syndrome, is involved in human parathyroid tumorigenesis

      ea0026p56
    • Clinicopathological characteristics of pancreatic neuroendocrine tumors at diagnosis

      ea0026p57
    • A large adrenal tumour as a phenotypic manifestation of the Birt-Hogg-Dube syndrome

      ea0026p58
    • Metabolic syndrome related to adrenal incidentaloma: observational study

      ea0026p59
    • Development and characterisation of patient-individual tumor models for endocrine tumors

      ea0026p60
    • Liposome based strategies for the treatment of adrenocortical carcinoma

      ea0026p61
    • Injection systems for long-acting somatostatin analogs: a comparative assessment of preparation times and nurses' perceptions

      ea0026p62
    • The influence of different ACTH assays on the ACTH concentrations of patients with small cell lung cancer

      ea0026p63
    • Primary hyperparathyroidism in MEN1 patients: preferred surgical procedure and relation with genotype

      ea0026p64
    • Significance of BRAF expression in nodular thyroid disease: prognostic and therapeutic implications

      ea0026p65
    • Metabolic endocrine tumor activity is reflected by total 18F-DOPA PET tumor uptake in patients with a carcinoid tumor

      ea0026p66
    • Ectopic mediastinal parathyroid adenoma: a case report

      ea0026p67
    • Significant prognostic survival factors in patients with pancreatic neuroendocrine tumors

      ea0026p68
    • Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): is it linked to GH secretion?

      ea0026p69
    • First prognostic analysis of stage III adrenocartical carcinoma patients after complete resection: a retrospective French Multicentric Study from the INCA-COMETE network

      ea0026p70
    • Comparison of the efficacy and the tolerance of high-dose calcium and pentagastrin tests in patients with cured or persistent medullary thyroid cancer and in controls

      ea0026p71
    • Distribution of mitotane and its two metabolites in liproprotein fractions of patients with adrenocortical carcinoma

      ea0026p72
    • 68Ga-DOTATATE PET shows a better diagnostic performance than octreoscan in patients with neuroendocrine tumors

      ea0026p73
    • In vitro effect of the somatostatin analogue BIM 23704 on cell cycle timecourse in an ovarian carcinoma cell line

      ea0026p74
    • T-type calcium channel blockers inhibit hormone secretion and induce apoptotic cell death in a medullary thyroid cancer cell line

      ea0026p75
    • Management of type III neuroendocrine tumors of the stomach

      ea0026p76
    • Could 99mTc labeled long-acting agonist of GLP-1 (Exendin-4) scintigraphy be a new tool in the diagnostics of unknown focus of insulinoma ? preliminary results

      ea0026p77
    • A randomized, double-blind, placebo-controlled, multicenter phase III trial of everolimus + octreotide LAR versus placebo + octreotide LAR in patients with advanced neuroendocrine tumors (NET) (RADIANT-2): updated safety results

      ea0026p78
    • A randomized, double-blind, placebo-controlled, multicenter phase III trial of everolimus in patients with advanced pancreatic neuroendocrine tumors (PNET) (RADIANT-3): updated safety results

      ea0026p79
    • Mitotane reduces the chemoresistance phenotype in an adrenocortical carcinoma cell line

      ea0026p80
    • Treatment of patients with metastatic well-differentiated gastroenteropancreatic tumors with RAD001(EVEROLIMUS)

      ea0026p81
    • The role and extend of surgical resection in patients with gastric carcinoid tumours type 1

      ea0026p82
    • Effectiveness of zolendronic acid yearly for preventing bone loss in patients with neuroendocrine tumors on somatostatin analogue therapy

      ea0026p83
    • The demethylating agent 5-aza-2-deoxycytidine upregulates somatostatin type 2 receptor expression and enhances internalization of radiolabeled somatostatin analogue in human carcinoid tumour cells

      ea0026p84
    • Comments on a series of patients affected by MEN1

      ea0026p85
    • Role of peptide receptor radionuclide therapy (PRRT) in well and moderately differentiated neuroendocrine tumours

      ea0026p86
    • Anatomical distribution of primary adrenal tumors: 10-year single center experience

      ea0026p87
    • cAMP induces PATZ1 and estrogen receptor [beta] nuclear re-localization in the human seminoma TCam-2 cell line

      ea0026p88
    • The management of thyroid nodule in a patient with a non-thyroid primary cancer

      ea0026p89
  • Female reproduction
  • • Ovulation induction by metformin in lean and obese women with polycystic ovary syndrome

      ea0026p90
    • Detection and exploring the left shift kurtosis of the fertile window in ovulatory cycles by biophysical biomarkers of the cervical secretion: case report

      ea0026p91
    • Prevalence of thyroid pathologies in patients with polycystic ovary syndrome

      ea0026p92
    • Metformin treatment with or without life style changes in the polycystic ovary syndrome

      ea0026p93
    • Development of a mouse model with polycystic ovary syndrome

      ea0026p94
    • Kisspeptin: new marker of placental dysfunction?

      ea0026p95
    • Tissue specific regulation of CGB gene expression in the common marmoset (Callithrix jacchus) by SP-1 and AP-2

      ea0026p96
    • Sexual dysfunction in polycystic ovary syndrome

      ea0026p97
    • Oligo-amenorrhea and hyperandrogenaemia in postmenarcheal adolescence

      ea0026p98
    • Cardiovascular disease risk markers in women with polycystic ovary syndrome: systematic review and meta-analysis

      ea0026p99
    • The aldosterone/renin ratio during administration of oral contraceptives with different types of gestogens

      ea0026p100
    • Inhibitory effect of DHEAS on leiomyoma growth

      ea0026p101
    • The importance of PIK3R1 gene in polycystic ovary syndrome

      ea0026p102
    • Effect of paraoxonase genes on metabolic profile of women with polycystic ovary syndrome

      ea0026p103
    • Glucocorticoid-induced leucine zipper (GILZ), a factor which controls tumor cell proliferation, is estradiol responsive in epithelial ovarian cancer

      ea0026p104
    • rs7566605 SNP of INSIG2 gene is not associated with the polycystic ovary syndrome diagnosis and its phenotypic traits in Romanian subjects

      ea0026p105
    • C-peptide serum concentration in obese women with polycystic ovary syndrome

      ea0026p106
    • Higher metabolic risk with nih diagnostic criteria versus rotterdam criteria for polycystic ovarian syndrome

      ea0026p107
    • Relation of insulin resistance and lipid peroxidation in non-obese women with polycystic ovary syndrome

      ea0026p108
    • PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis

      ea0026p109
    • MTHFR mutations in female patients with autoimmune thyroiditis

      ea0026p110
    • Plasma testosterone fractions in women with hyperandrogenism

      ea0026p111
    • Polycystic ovary syndrome and autoimmunity

      ea0026p112
    • 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (71A/G HSD17B5 SNP) and effects of oral contraceptive pill on hirsutism, androgens and metabolic profile in non-obese PCOS women: a pilot study

      ea0026p113
    • Does uric acid predict insulin resistance in polycystic ovary syndrome?

      ea0026p114
    • Injected FSH overriding ageing related elevated FSH through high activity of the hypothalomo-pituitary axis, enforces wanted multiple follicle growth in women undergoing IUI

      ea0026p115
    • The influence of LH substitution for GnRH antagonist blocked endogenous LH in older IVF patients

      ea0026p116
    • Adiponectin and metabolic syndrome in PCOS patients - beyond obesity

      ea0026p117
    • Ovarian ageing and twinning

      ea0026p118
    • The role of metabolic hormones ghrelin, leptin and obestatin in control of ovarian functions

      ea0026p119
    • Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 Caucasian patients with polycystic ovary syndrome

      ea0026p120
    • Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest

      ea0026p121
    • Abstract unavailable

      ea0026p122
    • Self-reported health related quality of life and depression in women with polycystic ovary syndrome: associations with selected metabolic and hormonal PCOS features.

      ea0026p123
    • Two hormone for one receptors: dissecting out LH and hCG activity with an in vitro approach.

      ea0026p124
    • Anti-mullerian hormone as a predictor of ovarian response to metformin in lean women with polycystic ovary syndrome

      ea0026p125
    • Cigarette smoking and progesterone and androgen metabolites in premenopausal women

      ea0026p126
    • Influence of smoking cessation on steroid spectrum in premenopausal women

      ea0026p127
    • Metabolic and cardiovascular outcomes in adult patients with turner's syndrome under hormonal replacement therapy

      ea0026p128
  • Growth factors
  • • Extreme ketogenic, but not moderate, low-carbohydrate/high fat diets lead to loss of lean body mass in rats due to impairments of the GH/IGF system

      ea0026p129
    • Zilpaterol hydrochloride effects on carcass composition, growth performance and blood metabolites of Lory Bakhtyary lambs

      ea0026p130
    • Comparative characterization of influence of replacement therapy with growth hormone on the level of secretion of growth hormone, insulin-like growth factor-1 and binding protein-3 in girls with endocrine and hereditary types of stunting

      ea0026p131
    • Bone turnover and mineral density in thalassemia: relationships with gh secretory status and circulating somatomedins

      ea0026p132
    • Effects of the d3 GHR allele on disease activity in acromegalic patients

      ea0026p133
    • Circulating insulin-like growth factor 1 (IGF1) and mortality: meta-analysis and dose-response meta-regression

      ea0026p134
    • Long acting analogs of glycoprotein hormones developed by using gene fusion and gene transfer are safe for use in human

      ea0026p135
  • Male reproduction
  • • Experience with a 1% testosterone gel in treatment of aging males with hypogonadism and type 2 diabetes mellitus

      ea0026p136
    • Hypogonadism, insulin resistance and visceral adiposity in myotonic dystrophy

      ea0026p137
    • Perceived ejaculate volume reduction in subjects with erectile dysfunction: psycho-biological correlates

      ea0026p138
    • Perceived reduced sleep-related erections in subjects with erectile dysfunction: psycho-biological correlates

      ea0026p139
    • Sexual interests and hypogonadism in Prader-Willi syndrome (PWS)

      ea0026p140
    • Erectile dysfunction does not mirror endothelial dysfunction in hiv-infected patients

      ea0026p141
    • P450 aromatase over-expressing mice (AROM+) as a model for infertility in men

      ea0026p142
    • The obstructive azoospermia and TESA-ICSI

      ea0026p143
    • Does local testosterone therapy in adult men measure up to the 2006 Endocrine Society's Guidelines?

      ea0026p144
    • Criptorchidism, varicocele, azoospermia and Leydig cell tumor in a couple of identical twins with a unique de novo balanced reciprocal translocation.

      ea0026p145
    • Transcriptional regulation of germ cell differentiation.

      ea0026p146
    • Efficacy of recombinant human follicle-stimulating hormone (rhFSH) in the treatment of male-factor infertility.

      ea0026p147
    • Testosterone changes over time in men with human immunodeficiency virus infection: preliminary results

      ea0026p148
    • Intramuscular testosterone undecanoate for substitution in male hypogonadism - the experience of 13.5 years

      ea0026p149
    • Testosterone administration to hypogonadal men for a period of up to 42 months improves features of the metabolic syndrome

      ea0026p150
    • Safety of 42 months of treatment with of long-acting parenteral testosterone undecanoate in men with late-onset hypogonadism

      ea0026p151
    • Expression of ghrelin receptor GHSR-1a in mammalian spermatozoa and their response to ghrelin in vitro

      ea0026p152
    • Lower serum testosterone and estradiol (E2) in adult men with unfused epiphyses due to unrecognized and untreated congenital hypogonadotropic hypogonadism: evidence for an E2 threshold for bone maturation in men

      ea0026p153
    • Erectile dysfunction in endocrine patients (pituitary diseases)

      ea0026p154
  • Neuroendocrinology
  • • Short-term balneotherapy is associated with changes in salivary cortisol levels

      ea0026p155
    • Character of macrovascular complications as per the Uzbekistan National Register of patients with the combined diabetes mellitus and diabetes insipidus

      ea0026p156
    • Clinical presentation peculiarities of constitutional puberty delay in boys

      ea0026p157
    • Evaluation of the questionnaire for revealing of GH deficiency in adults with various pituitary adenomas

      ea0026p158
    • Frequency of secondary GH deficit in patients with acromegaly undergone radiation or surgical treatment

      ea0026p159
    • Hormonal disorders in patients with acromegaly in Khorezm region, Republic of Uzbekistan

      ea0026p160
    • Incidence of diabetes mellitus and diabetes insipidus combination in the Republic of Uzbekistan

      ea0026p161
    • Incidence of puberty delay risk factors in boys

      ea0026p162
    • Structure of neuroendocrine disorders rate in patients with different pituitary adenomas (retrospective analysis)

      ea0026p163
    • Sexual desire in female-to-male transsexual persons

      ea0026p164
    • Role of IGF1 system in human longevity. A study in a wide population of centenarians and centenarians' offspring

      ea0026p165
    • Evaluation of insulin secretion and sensitivity and lipid profile in GH deficient children before and at the end of rhGH therapy

      ea0026p166
    • Immune status and functional activity of blood neutrophils in patients with active acromegaly

      ea0026p167
    • Dexamethasone supression test (BDST) and bilateral inferior petrosal sinus sampling (BIPSS) in diagnosis of ACTH: dependent hypercortisolism

      ea0026p168
    • The NAD- and NADP-dependent blood lymphocytes dehydrogenases activity in acromegaly

      ea0026p169
    • Metabolic encephalopathy and quadriparesis induced by severe hyponatremia in the patient with Sy Seehan

      ea0026p170
    • Effects of orexin-monoaminergic interactions on vasopressin secretion in rat neurohypophyseal cell cultures

      ea0026p171
    • Age related distribution of the endothelial nitric oxide synthase gene G894T polymorphism: relationship with metabolic-endocrine and cognitive features

      ea0026p172
    • Glucose homeostasis in GH deficient adults not treated with GH: more than 10 year follow-up

      ea0026p173
    • A raised GR[alpha]/[beta] expression ratio in monocytes of schizophrenic and bipolar patients

      ea0026p174
    • The role of food choice in the effects of a high-fat high-sugar diet on leptin sensitivity

      ea0026p175
    • Hypothalamic neuropeptide Y controls the hepatic secretion of VLDL triglycerides in rats via the sympathetic nervous system

      ea0026p176
    • Inverse association of dehydroepiandrosterone sulfate with stroke severity and poor functional outcome in a female stroke population

      ea0026p177
    • Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations

      ea0026p178
    • X-linked adrenoleukodystrophy: an intersection between Endocrinology and Neurology

      ea0026p179
    • Targeting PKC in human pancreatic neuroendocrine tumor cells

      ea0026p180
    • GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis

      ea0026p181
    • Glycoproteic pituitary hormones in the cerebrospinal fluid of patients with pituitary adenomas

      ea0026p182
    • Hipothalamo-pituitary-adrenal axis function in posttraumatic stress disorder

      ea0026p183
    • Vasopressin and vasopressin receptor expression in the rodent retina

      ea0026p184
    • Serum leptin levels in patients with Alzheimer's disease

      ea0026p185
    • Estrogen signaling in the hypothalamus regulates glucose metabolism in female rats

      ea0026p186
    • The role of the Diphereline (Triptoreline) test in the etiological diagnosis of gonadal dysfunction

      ea0026p187
    • Glucocorticoid receptor gene polymorphisms are associated with disease course during pregnancy and the post-partum period in rheumatoid arthritis

      ea0026p188
    • Cabergoline influence on antioxidative protection enzymes activity in complex therapy in patients with non-functioning pituitary adenoma (NFPA)

      ea0026p189
    • The role of centrally applied ghrelin on hypothalamic AMPK activity and pituitary-adrenal responses in differently fed rats

      ea0026p190
  • Pituitary
  • • The treatment with dopamine agonists are not associated with increased prevalence of cardiac-valve regurgitation in patients with prolactinomas and acromegalia

      ea0026p191
    • Adipocytes as a source of increased circulating levels of NAMPT/visfatin in active acromegaly

      ea0026p192
    • Pituitary mycosis complicating a Cushing's macroadenoma

      ea0026p193
    • Immunopositive ACTH cells in juvenile female rats after treatment with estradiol

      ea0026p194
    • A case of an ectopic prolactinoma

      ea0026p195
    • Coping strategies in patients after treatment for functioning or non-functioning pituitary adenomas

      ea0026p196
    • Polycystic ovary syndrome and prolactinoma association

      ea0026p197
    • Effects on metabolic parameters after 12-month treatment with a new once-a-week sustained release recombinant growth hormone (LB03002) in adult patients with GH deficiency (GHD)

      ea0026p198
    • Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency

      ea0026p199
    • Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult onset GH deficiency

      ea0026p200
    • Evaluation of aortic stiffness in the acromegaly patients with remission

      ea0026p201
    • Baseline characteristics and effects of 10 years of GH replacement therapy in adults previously treated with pituitary irradiation therapy

      ea0026p202
    • Effects of dopamine agonist on heart and lung in patients receiving dopamine agonist due to hyperprolactinemia

      ea0026p203
    • Efficacy of transsphenoidal surgery in treatment of Cushing's disease: factors influencing postsurgical outcome

      ea0026p204
    • LHRH-antagonist cetrorelix may reduce postmenopausal flushing

      ea0026p205
    • O-6 methylguanine-DNA methyl transferase (MGMT) immunoexpression in GH secreting pituitary adenomas and it's correlation with Ki-67 labeling index (Ki-67 LI)

      ea0026p206
    • Mechanism of anterior pituitary gene regulation by LHX3 in paediatric combined pituitary hormone deficiency

      ea0026p207
    • High risk of central adrenal insufficiency in GH deficient long-term survivors of childhood acute lymphoblastic leukaemia

      ea0026p208
    • Rationale and design of a global hyponatraemia registry

      ea0026p209
    • Screening of Cushing's syndrome and Acromegaly in Japanese diabetic patients

      ea0026p210
    • Gender-related differences in prolactinomas

      ea0026p211
    • Efficacy and safety of the use of the recombinant GH receptor antagonist pegvisomant (PGV) in acromegaly. Evaluation of its use in 13 patients treated in a pituitary disorders unit

      ea0026p212
    • Hypothalamic tumor in a patient with Pendred syndrome

      ea0026p213
    • Multimodal treatment and minimally invasive surgery for 117 pituitary adenomas: a Croatian Pituitary Centre experience

      ea0026p214
    • Illness perceptions, quality of life and self-reported physical symptoms in patients after long-term remission of Cushing's syndrome

      ea0026p215
    • Long-term treatment of acromegaly with pegvisomant (Somavert): cross-sectional observations from ACROSTUDY, a post-marketing, international, safety, surveillance study

      ea0026p216
    • Pituitary gland function following craniocerebral trauma III[deg] in younger patients

      ea0026p217
    • Macroprolactinomas in 38 children and adolescents: sex differences and long-term results of medical treatment

      ea0026p218
    • Medical treatment of an agressive non-secreting pituitary tumor and non-secreting pituitary carcinoma: a report of two cases

      ea0026p219
    • Normal pregnancy in a woman with history of panhypopituitarism due to lymphocytic hypophysitis

      ea0026p220
    • PANCH tumor in a female patient

      ea0026p221
    • On the effect of CRH and dexamethasone on Pomc synthesis and ACTH secretion in rat pituitary primary cultures

      ea0026p222
    • KIT protein expression and mutational status of KIT gene in pituitary adenomas

      ea0026p223
    • Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly

      ea0026p224
    • Effect of GH as add-on treatment in severe fibromyalgia syndrome. Results from the IIIb, CT27560 placebo-controlled, multicenter trial

      ea0026p225
    • Tumor occurrence or recurrence after five year GH replacement theraphy

      ea0026p226
    • Pituitary function in type 2 diabetic men with good or poor glycaemic control

      ea0026p227
    • Non-traditional effects of GH: a survival factor for retinal ganglion cells

      ea0026p228
    • Clinical and subclinical apoplexy in nonfunctioning pituitary tumors: clinical features, management and outcome

      ea0026p229
    • Comparison of GH suppression response after oral and intravenous glucose tolerance tests in healthy subjects

      ea0026p230
    • The reliability of GH stimulation tests in the diagnosis of childhood GH deficiency

      ea0026p231
    • Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome: revisiting the direct and indirect water deprivation tests

      ea0026p232
    • GH replacement therapy in elderly GH deficient patients: a systematic review

      ea0026p233
    • Does GH replacement therapy reduce mortality in adults with GH deficiency? Data from the Dutch National Registry of GH Treatment in adults

      ea0026p234
    • Hormonal effects on cardiovascular function in patients with acromegaly

      ea0026p235
    • Expression of canonical Wnt proteins and survivin in pituitary tumours

      ea0026p236
    • Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly

      ea0026p237
    • Improvement of acromegalic cardiomyopathy following pituitary apoplexy

      ea0026p238
    • Pituitary apoplexy as initial manifestation of pituitary tumors: two case reports

      ea0026p239
    • Detection of antipituitary antibodies using human and primate pituitary glands in patients with autoimmune thyroid disease and diabetes mellitus type 1

      ea0026p240
    • Periodontal disease ferquency in acromegalic patients

      ea0026p241
    • Relationship between GH activity and markers of inflammation: a cross-over study of healthy volunteers treated with GH and a GH antagonist for 3 weeks

      ea0026p242
    • Diabetes mellitus as adjunctive risk factor for vertebral fractures in men with acromegaly

      ea0026p243
    • Hyperprolactinemia is a risk factor for radiological vertebral fractures in post-menopausal women

      ea0026p244
    • Efficacy of weekly pegvisomant monotherapy

      ea0026p245
    • AcroBel-2: the Belgian follow-up survey on acromegaly: contribution of pituitary surgery and the use of pegvisomant to an improvement in disease control

      ea0026p246
    • A multicenter study on acromegalic patients treated with pegvisomant monotherapy or with pegvisomant plus somatostatin analogues: role of exon 3 deleted GH receptor polymorfism

      ea0026p247
    • Detection of acromegaly by automatic face classification software

      ea0026p248
    • Prolactinoma cell culture: experimental model for tumor growth

      ea0026p249
    • Evolution of invasive treatment-resistant prolactin (PRL) adenoma

      ea0026p250
    • Lost to follow-up in acromegaly, results of ACROSPECT observational study

      ea0026p251
    • Initial management and complications of Cushing disease (CD): a French multicenter study of 437 patients

      ea0026p252
    • The value of T2 weighted MR-imaging for stratification to medical therapy in newly diagnosed acromegaly

      ea0026p253
    • Lack of efficacy of 24-month treatment with the GH receptor antagonist pegvisomant in patient with active acromegaly resistant to long-term, high-dose somatostatin analog treatment: effects on IGF1 and GH levels

      ea0026p254
    • Quality of life and cortisol diurnal rhythm after 3 months of medical treatment for Cushing's disease

      ea0026p255
    • Low incidence of adrenal insufficiency after transsphenoidal surgery in patients with acromegaly: a long-term follow-up study

      ea0026p256
    • Fertility rate in acromegalic women: a single center experience on 70 patients before and after treatment

      ea0026p257
    • Prevalence of germline mutations of AIP gene in sporadic aggressive somatotropinomas

      ea0026p258
    • Predictive markers of recurrence in radically resected pituitary macroadenomas

      ea0026p259
    • Mechanism and management of hyperglycemia associated with pasireotide: results from studies in healthy volunteers

      ea0026p260
    • The efficacy of octreotide LAR in acromegalic patients

      ea0026p261
    • A novel AIP mutation related to familial isolated pituitary adenomas (FIPA)

      ea0026p262
    • Octreotide pharmacokinetics and biochemical control of acromegaly using a subcutaneous octreotide hydrogel implant

      ea0026p263
    • Transition to endoscopic transsphenoidal pituitary surgery: a single-center experience

      ea0026p264
    • Pasireotide (SOM230) demonstrates efficacy in patients with Cushing's disease: results from a large, randomized-dose, double-blind, Phase III study

      ea0026p265
    • Clonality analysis of pituitary adenomas: a pilot study

      ea0026p266
    • Effect of gender and on the invasiveness of prolactinomas

      ea0026p267
    • Frequency of acute-onset symptoms and other features of craniopharyngioma presentation in children and adults

      ea0026p268
    • Macroprolactinomas and pregnancy: analysis of a 38-women cohort treated by dopamine agonists

      ea0026p269
    • Primary empty sella is associated with increased cardiovascular risk, regardless the occurrence of pituitary dysfunction

      ea0026p270
    • Evaluation of health-related quality of life in patients with Cushing's disease and patients with non-functioning pituitary adenomas

      ea0026p271
    • Topoisomerase II [alpha] expression in human pituitary adenomas as the prognostic factor

      ea0026p272
    • Cyclooxygenase 2 expression in human pituitary adenomas

      ea0026p273
    • Recent changes in clinical presentation and therapeutic approach in MEN1-related pituitary adenomas

      ea0026p274
    • Prolactinoma and thyroid function

      ea0026p275
    • Late development of resistance to cabergoline in a giant macroprolactinoma with aggressive carvenous sinus and spheinodal bone invasion

      ea0026p276
    • Minimal active acromegaly may be effectively treated by prolonged injections of octreotide LAR

      ea0026p277
    • Radiological features of breast benign lesions in patients with hyperprolactinemia

      ea0026p278
    • A patient with ACTH-dependent Cushing's syndrome and an unexpected neuropathogical diagnosis

      ea0026p279
    • Immunoglobulin G4-related infundibulo-hypophysitis: report of 4 cases and review of the literature

      ea0026p280
    • Assessment of retinopathy in acromegaly

      ea0026p281
    • Success rate of surgery in patients with macroprolactinoma

      ea0026p282
    • GH deficiency in cured acromegalic patients: metabolic effects of recombinant hGH replacement

      ea0026p283
    • Improvement in clinical signs and symptoms of Cushing's disease following 12 months' pasireotide therapy

      ea0026p284
    • Pituitary calf transplantation into the human, 50 years after

      ea0026p285
    • The impact of transsphenoidal surgery on glucose homeostasis and insulin resistance in acromegaly

      ea0026p286
    • Tumor size and parasellar extension influence on macroprolactinomas' outcome

      ea0026p287
    • Pegvisomant therapy in acromegaly: a multicenter observational study

      ea0026p288
    • ACTH-secreting pituitary adenomas express higher SSTR5 than SSTR2 protein levels by immunohistochenistry using new monoclonal antibodies against SST-binding domains

      ea0026p289
    • Cardiac risk in patients with treatment naive, first-line medically controlled and first-line surgically cured acromegaly in comparison to matched data from the general population

      ea0026p290
    • GH receptor mRNA expression and the effect of pegvisomant on GH secretion by somatotroph pituitary adenomas

      ea0026p291
    • Carotenoids inhibits cell proliferation, arrest cell cycle and induces apoptosis in pituitary tumor cells

      ea0026p292
    • Prevalence of sleep apnea sindrome (SAS) in patients with acromegaly

      ea0026p293
    • Patients previously treated for nonfunctioning pituitary macroadenomas have disturbed sleep characteristics, circadian movement rhythm, and subjective sleep quality

      ea0026p294
    • The dual PI3K/mTOR inhibitor NVP-BEZ235 has a potent antiproliferative action in human nonfunctioning pituitary adenomas

      ea0026p295
    • Primary pituitary tumors: 10-year single center experience

      ea0026p296
    • Pituitary apoplexy: clinical characteristics, circumstances of diagnosis and evolution in a Romanian patient series

      ea0026p297
    • Effects of short (6 months) and long (18 months) term treatment with GH-receptor antagonist pegvisomant (PEG) on rhythm disturbances in acromegaly

      ea0026p298
    • Pituitary dysfunction types and clinical presentation of pituitary microadenomas in childhood and adolescence

      ea0026p299
    • Secondary erythrocytosis due to acromegaly

      ea0026p300
    • Patients with active acromegaly (AA) have less hepatic triglyceride than normal subjects using proton magnetic resonance spectroscopy (1H MRS)

      ea0026p301
  • Obesity
  • • Obesity in GDM

      ea0026p302
    • Obesity, metabolic syndrome, hepatic steatosis, fibrosis and viral load as negative factors affecting early (EVR) and sustained (SVR) virological response in patients with chronic hepatitis c treated with peginterferon and ribavirin

      ea0026p303
    • Abstract unavailable

      ea0026p304
    • Testosterone therapy increased muscle mass and lipid oxidation in ageing men

      ea0026p305
    • Development and characterization of high-affinity leptins and leptin antagonists

      ea0026p306
    • Ghrelin effects on nutrition and digestion in pest insects

      ea0026p307
    • TNF[alpha] plays an essential role in the downregulation of sex hormone-binding globulin production by decreasing hepatic HNF-4[alpha] through NF-[kappa]B activation

      ea0026p308
    • Benzofran derivatives inhibit 11[beta]-hydroxysteroid dehydrogenase type 1 in rodent adipose tissue

      ea0026p309
    • Effect of dehydroepiandrosterone on 11[beta]-hydroxysteroid dehydrogenase type 1 in rodent adipocytes

      ea0026p310
    • Waist circumference is a better predictor of cardiovascular risk than body mass index in patients with type 2 diabetes mellitus

      ea0026p311
    • Effects of natural dietary antioxidants on insulin and IGF1 in obese patients with insulin resistance

      ea0026p312
    • Envirometal and metabolic risk factors of obesity development in preschool children

      ea0026p313
    • Gender differences of leptin receptor gene genotypes and leptin levels in obese children

      ea0026p314
    • Testosterone and metabolic syndrome: a meta-analysis study

      ea0026p315
    • Identification of a reliable biomarker for metabolic syndrome

      ea0026p316
    • Serum Vitamin D and IGF1 levels in abdominal obesity women

      ea0026p317
    • Serum adiponectin levels in patients with type 1 gaucher disease

      ea0026p318
    • Undiagnosed thyroid dysfunction, leptin and body mass index

      ea0026p319
    • Low birth weight and obesity are associated with increased androgen levels among children with premature adrenarche

      ea0026p320
    • Prevalence of metabolic syndrome in 850 obese children from infancy to adolescence

      ea0026p321
    • The effect of androgens on adipose tissue in PCOS

      ea0026p322
    • Functional differences between visceral and subcutaneous fat pads originate in the adipose stem cell

      ea0026p323
    • Basal energy expenditure and fat mass changes in breast cancer patients

      ea0026p324
    • Waist line radius to subcutaneous adipose tissue thickness- better insight to lipid stores centralisation

      ea0026p325
    • Serum leptin level and its association with body composition in obese children

      ea0026p326
    • Inflammatory T-lymphocyte proliferation in morbid obesity

      ea0026p327
    • Letrozole normalizes serum testosterone but has no clinical effects in men with obesity-related hypogonadotropic hypogonadism

      ea0026p328
    • Small animal PET/CT imaging reveals altered in vivo insulin function in brown adipose tissue of obese mice

      ea0026p329
    • Haematic circulating endocannabinoids (ECs) in lean, overweight and obese: the role of the gender

      ea0026p330
    • Enhanced muscle mass by ALA treatment increase myostatin-mediated pathways in adipose tissue

      ea0026p331
    • Effects of food, hormones and autonomic nervous activity on rhythmic expression of clock genes and metabolic genes in rat white adipose tissue

      ea0026p332
    • Investigating the role of FTO in obesity: dysregulation of satiety signalling

      ea0026p333
    • Synergistic post-prandial deregulation of orexigenic and anorexigenic systems in obesity

      ea0026p334
    • Long-term effects of normalization of testosterone on variables of the metabolic syndrome in hypogonadal men: the moscow study

      ea0026p335
    • Therapy with exenatide in obese and morbidly obese type 2 diabetic patients: comparative analysis

      ea0026p336
    • Vitamin D and obesity

      ea0026p337
    • Glimepiride improves insulin sensitivity in oxidative skeletal muscle of obese rats: possible association between GLUT4 and SUR2A expressions

      ea0026p338
    • The relationship between adiposity and carbohydrate metabolism, by age and gender in Vlora, a city in Albania

      ea0026p339
    • Long term low intensity recreational physical exercise attenuates colonic inflammation in rats: the role of heme oxygenase system

      ea0026p340
    • Effects of Orexin-A on AMPK activity

      ea0026p341
    • Monitoring the efficacy of long term low intensity physical exercise programmes by the laboratory and hormone profile of obesity

      ea0026p342
    • 3-iodothyronamine metabolism and metabolic effects in rat white adipocytes

      ea0026p343
    • The modulation of brain derived neurotrophic factor (bdnf) during exercise in obesity

      ea0026p344
    • The modulation of atrial natriuretic peptide levels during exercise in obesity

      ea0026p345
    • AM251, a CB1 receptor antagonist, increases GLUT4 expression in adipocytes

      ea0026p346
    • Serum homocysteine levels in patients with nonalcoholic fatty liver disease

      ea0026p347
    • Body mass index, obesity and hyperuricemia in postmenopausal women

      ea0026p348
  • Steroid metabolism
  • • Beneficial effects of testosterone supplementation on prostatitis-like alterations in an animal model of metabolic syndrome

      ea0026p349
    • Testosterone supplementation improves adipose tissue function in an animal model of metabolic syndrome

      ea0026p350
    • Evaluation of a method to measure long term cortisol levels in health and disease

      ea0026p351
    • Effect of smoking cessation on steroid balance in postmenopausal women

      ea0026p352
    • Activin A regulates local testosterone production and growth in prostate cancer through 17[beta]-hydroxysteroid dehydrogenase

      ea0026p353
    • Standardized high throughput LC-MS/MS steroid-quantification for clinical metabolomics

      ea0026p354
    • Salivary cortisol and testosterone: a comparison of salivary sample collection methods in healthy controls

      ea0026p355
    • Hormonal parameters and sex hormone receptor gene polymorphisms in males with autoimmune diseases

      ea0026p356
    • Inhibitory effect of glucocorticoids on GLUT4 expression in visceral adipose tissue may be determined by increased 11[beta] hydroxysteroid dehydrogenase 1 (11[beta]-HSD1) expression

      ea0026p357
    • Chronic effect of 17[beta] estradiol on GLUT4 expression in 3T3-L1 adipocytes

      ea0026p358
  • Nuclear receptors
  • • Oleic and linoleic fatty acids reduce the SLC2A4 gene expression: the involvement of the NFkappaB and HIF-1a transcriptional factors

      ea0026p359
  • Adrenal medulla
  • • Pheochromocytoma: a complex case

      ea0026p360
    • Head and neck paragangliomas: genetic spectrum and clinical variability in 101 consecutive patients

      ea0026p361
    • Succinate dehydrogenase (SDH) mutations: biochemical and functional effects in pheochromocytoma/paraganglioma tissues

      ea0026p362
    • Expression of IGF/mTOR pathway components in human pheochromocytomas and in vitro inhibition of PC12 rat pheochromocytoma cell growth by mTOR inhibitors

      ea0026p363
    • Unusual mutation spectrum in Hungarian patients with apparently sporadic pheochromocytomas

      ea0026p364
    • Pheochromocytoma occurs in Saudi patients with MEN 2A

      ea0026p365
    • Impact of surgery upon lipid profile in a case series of pheochromocytoma

      ea0026p366
  • Signal transduction
  • • Transmenbrane potential ([Delta][psi]p) slight changes in non-excitable individual cells at short-term hormone action

      ea0026p367
    • Research resource for analysing functional data of glycoprotein hormone receptors: novel tools to gain deeper insights into molecular mechanisms

      ea0026p368
    • Different and common transmembrane activation mechanisms between glycoprotein hormone receptors and other G-protein coupled receptors

      ea0026p369
    • Distribution of 3-iodothyronamine and trace amine-associated receptors in mouse

      ea0026p370
  • Thyroid (non cancer)
  • • Minimally invasive video-assisted thyroidectomy versus conventional thyroidectomy: a single-blinded, randomized controlled clinical trial

      ea0026p371
    • Complications after thyroidectomy: a 10 years experience in a District General Hospital

      ea0026p372
    • Risk factors for morbidity after thyroid surgery: analysis of 559 cases

      ea0026p373
    • Acoustic radiation force impulse imaging of thyroid gland

      ea0026p374
    • The influence of cure of subclinical hyperthyroidism on left ventricular walls thickness and mass index

      ea0026p375
    • The use of lithium and perchlorate therapy in special cases of hyperthyroidism

      ea0026p376
    • Comprehensive symptom profile in patients with nontoxic goiters: practicability and sensitivity of the new symptom assessment tool CSP-ThSF22

      ea0026p377
    • Selenium treatment in chronic autoimmune thyroid diseases

      ea0026p378
    • Comprehensive symptom profile in patients with toxic goiters: practicability and sensitivity of the new symptom assessment tool CSP-ThHyperSF27

      ea0026p379
    • A case of Riedel's thyroiditis

      ea0026p380
    • Molecular analysis and functional significance of TSHR gene mutations in pediatric patients

      ea0026p381
    • Evolution of thyroid function and antibodies in Hashimoto thyroiditis after 10 years observation. Study on 1000 patients

      ea0026p382
    • Hashimoto's thyroiditis is not associated with breast cancer more than other thyroid condition or more than general population

      ea0026p383
    • Occurrence and prognostic impact of hypothyroidism in chronic heart failure

      ea0026p384
    • Serum lipid oxidation and paraoxonase enzyme activity in subclinical thyrotoxicosis

      ea0026p385
    • Undiagnosed subclinical hypothyroidism, health indicators and cardiovascular risk factors in a Mediterranean population

      ea0026p386
    • Current results on urinary iodide excretion in pregnant women on the day of childbirth in Germany

      ea0026p387
    • Tear cytokines in endocrine ophthalmopathy (EOP)

      ea0026p388
    • The CT60 and Jo31 polymorphisms of CTLA-4 gene are associated with disease progression in Graves' disease

      ea0026p389
    • Hyperthyroidism in pregnancy: therapeutic decisions

      ea0026p390
    • The association between serum TSH levels and hypertension in 12 353 children and adolescents

      ea0026p391
    • Increased Th1 response and regulatory CD4+CD25+CD127low/-FoxP3+ T cells in patients with chronic hepatitis C virus infection developing interferon-induced thyroiditis

      ea0026p392
    • Study of the relation between subclinical hypothyroidism and diabetic complications

      ea0026p393
    • Melatonin drug use in complex treatment of hypothyroidism manifest

      ea0026p394
    • MPV levels in patients with overt hypothyroidism before and after levothyroxine treatment

      ea0026p395
    • Epidemiologic study of iodine deficiency in 6 regions of the Republic of Uzbekistan

      ea0026p396
    • Thyroid status and health-related quality of life in the LifeLines-cohort

      ea0026p397
    • Subclinical hypothyroidism and thyroid autoimmunity: risk factors for coronary heart disease?

      ea0026p398
    • Faster response to cholestyramine added in treatment of patients with hyperthyroidism

      ea0026p399
    • The expression of keratin 34[beta]E12 in ectopic thymus tissue

      ea0026p400
    • Parathyroid cyst, a rare cause of cystic thyroid lesion

      ea0026p401
    • Clinical aspects in Graves' disease associated with infiltrative orbitopathy

      ea0026p402
    • Thyroid nodules in children: review of 67 patients

      ea0026p403
    • The etiologic profile of thyromegaly in children in the south west of Romania between 2005 and 2010

      ea0026p404
    • Awareness of secondary hypothyroidism in GH deficient hypopituitary adults has improved their lipid status

      ea0026p405
    • Cytological evaluation of pyramidal lobe and thyroglossal duct cysts

      ea0026p406
    • The outcome of radioiodine therapy after 10 years in patient with toxic nodular goiter

      ea0026p407
    • The effect of radioiodine therapy in patients with non-toxic goiter with hot nodules on thyroid scan

      ea0026p408
    • The induction of hyperthyroidism in patient with non-toxic goiter after radioiodine therapy: a case report

      ea0026p409
    • Lithium in the acute preoperative preparation of thyrotoxicosis: a case series

      ea0026p410
    • Thyroid peroxidase antibodies in euthyroid children: is long term follow up required?

      ea0026p411
    • Increasing saturation with thyroid hormones is associated with haemostatic system activation

      ea0026p412
    • Sclerosing Hashimoto's thyroiditis: a case presentation

      ea0026p413
    • Does levothyroxine plus thyrostatic drug titrated individually offer better control of hyperthyreoidism than thyrostatic alone?

      ea0026p414
    • Free T4 results in neonates: large differences between Immulite/VISTA and Vitros ECi

      ea0026p415
    • N-terminal pro B type natriuretic peptide levels in thyroid dysfunctions

      ea0026p416
    • Thyroid hormone levels are associated with body composition in healthy men

      ea0026p417
    • The efficacy of real-time ultrasound elastography in evaluation of thyroid nodules

      ea0026p418
    • The incidence of thyroid nodules in autoimmune thyroiditis in one endemic area

      ea0026p419
    • Analysis of T regulatory cells in young patients with dynamic of Graves' disease and Hashimoto's thyroiditis

      ea0026p420
    • Effects of thyroxin on pituitary and plasma GH levels in thyroidectomized: diabetic rats

      ea0026p421
    • The incidence of thyroid nodules in autoimmune thyroiditis in one endemic area

      ea0026p422
    • The regulatory role of neuroprotective nerve growth factor in Graves' ophthalmopathy

      ea0026p423
    • Biochemical abnormalities in MCT8 patients are due to abnormal thyroid hormone release from the thyroid and altered D1 activity

      ea0026p424
    • Changes in urinary iodine status following 10-year voluntary salt iodization in Latvia

      ea0026p425
    • Triiodothyronine stimulates cystatin C production and glucose transport in bone cells

      ea0026p426
    • Acoustic radiation force impulse elastography (ARFI) in patients with autoimmune thyroid disease

      ea0026p427
    • Proliferative potential of normo- and hyperfunctioning thyroid nodules

      ea0026p428
    • The effect of age on thyroid function and diagnostic significance of TRH test in elderly people

      ea0026p429
    • Improved prognosis in myxedema coma: happy ending of an old story: case report

      ea0026p430
    • The immunohistochemical demonstration of parafollicular cells and evaluation of calcium-phosphate balance in patients with thyroid hemiagenesis

      ea0026p431
    • The influence of radioiodine therapy on ophthalmologic symptoms and their relation to urine cotinine level in patients with Graves' disease

      ea0026p432
    • TSH receptor antibody measurement in the diagnosis of Graves' disease

      ea0026p433
    • Autoimmune hyperthyroidism triggered by 131I treatment for toxic nodular goitre: treatment with a second dose of 131I versus thyrostatics

      ea0026p434
    • The usefulness of human TSH-receptor antibody determination in the assessment of clinical activity of Graves' orbitopathy

      ea0026p435
    • Postpartum follow-up of women positively screened for thyroid disease in pregnancy: the necessity of a better care

      ea0026p436
    • CTLA4 exon1 A49G polymorphism in Slovak patients with rheumatoid arthritis and autoimmune thyroid disease

      ea0026p437
    • An unusual organ involvement in Werner syndrome: thyroid atrophy

      ea0026p438
    • Thyroid pathology in patients with type 1 diabetes mellitus

      ea0026p439
    • Goiter and epidemidology of autoimmune thyroiditis

      ea0026p440
    • Thyroid-associated ophtalmopathy (TAO) in association with another disorders

      ea0026p441
    • Evaluation of thyroid function test remission and relapse after low dose anti-thyroid drug therapy of Graves' disease, interim report of a long term retrospective study

      ea0026p442
    • Long-term follow-up of thyroid autoimmunity biomarkers in Graves' disease treated with low dose anti-thyroid medications (interim report)

      ea0026p443
    • Regulation of visceral adipose tissue-derived serin protease inhibitor in overt and subclinical hypothyroid patients

      ea0026p444
    • Thyroid function and mortality in euthyroid subjects

      ea0026p445
    • Vitamin D levels are associated with serum TSH levels but not with thyroid autoantibodies

      ea0026p446
    • Evaluation of thyroid surgery: 10 years of experience in a Military Hospital

      ea0026p447
    • Fine needle aspiration biopsy in thyroid nodular disease: 10 years of experience in a Military University Hospital

      ea0026p448
  • Thyroid cancer
  • • Routine serum calcitonin measurement in screening of medullary thyroid carcinoma (MTC) in Gohierri county

      ea0026p449
    • Coexistence of hyperparathyroidism with papillary thyroid microcarcinoma

      ea0026p450
    • Recombinant tsh-stimulated thyroglobulin measurements in patients with differentiated thyroid carcinoma with basal thyroglobulin <1 ng/ml

      ea0026p451
    • Thyroid disease in patients with type-1 neurofibromatosis: an underestimated issue?

      ea0026p452
    • Papillary thyroid microcarcinoma: size and metastatic behavior

      ea0026p453
    • Estrogen receptors and progesterone receptor expression and their relationship to types of thyroid cancer

      ea0026p454
    • The effects of four different tyrosine kinase inhibitors on medullary and papillary thyroid cancer cells

      ea0026p455
    • Thr300Ala ATG16L1 polymorphism influences susceptibility to and the prognosis of epithelial cell derived thyroid carcinoma

      ea0026p456
    • Reversine, an anti-cancer candidate, induces cell cycle arrest and apoptosis in human thyroid cancer

      ea0026p457
    • Intraindividual comparison of serum calcitonin levels after calcium versus pentagastrin stimulation

      ea0026p458
    • Classical and follicular variant papillary thyroid carcinoma: comparison of clinical, ultrasonographical, cytological and histopathological features in 402 patients

      ea0026p459
    • Serum 25-OH Vitamin D levels in patients with benign and malignant thyroid nodules

      ea0026p460
    • Role of 99mTc HYNIC Octreotide in the follow-up of thyroid cancer patients that after surgery and 131I therapy present raised thyroglobulin levels and negative 131I whole body scan

      ea0026p461
    • A case of calcitonin and CEA negative medullary thyroid carcinoma

      ea0026p462
    • Comparison of clinical and histopathological characteristics of thyroid papillary microcarcinoma and papillary thyroid carcinoma

      ea0026p463
    • Both Follicular and Papillary neoplasms in a patient with Hashimoto's thyroiditis: complete coincidence?

      ea0026p464
    • Association between thyroid autoimmunity and papillary thyroid carcinoma: recent confirmations from a prospective study

      ea0026p465
    • Primary malignant thyroid teratoma combined with papillary thyroid carcinoma in a female patient with Hashimoto thyroiditis

      ea0026p466
    • Differences between incidental and preoperatively diagnosed papillary thyroid microcarcinomas. Review of the last decade

      ea0026p467
    • A diagnostic value of elastosonographically determined strain index in the differential diagnosis of benign and malignant thyroid nodules

      ea0026p468
    • Diagnostic value of elastosonographically determined strain indexes in differentiated thyroid carcinomas

      ea0026p469
    • An uncommon thyroid tumor: hyalinizing trabecular adenoma

      ea0026p470
    • Differentiated thyroid cancer: primary tumor size and clinicopathologic features

      ea0026p471
    • Incidental papillary thyroid microcarcinoma: a retrospective study

      ea0026p472
    • Clinicopathologic significance of BRAF mutation in papillary thyroid carcinoma

      ea0026p473
    • Diagnostic performance and concordance analysis between ultrasonographic findings suggestive of malignancy and fine-needle aspiration (FNA) in eufunctional thyroid nodule

      ea0026p474
    • Prevalence and features of incidental thyroid carcinoma in 1955 patients surgically treated for benign lesions

      ea0026p475
    • Failure to supress TSH level in a thyroid cancer patient; a case report

      ea0026p476
    • Long term follow-up and outcome in thyroid papillary microcarcinoma

      ea0026p477
    • Incidentally discovered thyroid carcinomas. An experience of a centre through 18 years

      ea0026p478
    • Evaluation of safety and tolerability of calcitonin stimulation using high-dose calcium in patients with medullary thyroid carcinoma (MTC)

      ea0026p479
    • Comparison of calcitonin stimulation tests with pentagastrin (Pg) and high-dose calcium in patients with medullary thyroid carcinoma (MTC)

      ea0026p480
    • The value of CK19, Ki-67 and p53 expression in the diagnosis of thyroid follicular neoplasms

      ea0026p481
    • Does preoperative fine-needle aspiration decreases the thyroidectomy rates?

      ea0026p482
    • Malignancy rate is not different in dominant nodule and non- dominant nodule by fine needle thyroid aspiration

      ea0026p483
    • Seventh UICC/TNM staging criteria for medullary thyroid carcinoma: is there any prognostic advantage?

      ea0026p484
    • Very low-risk papillary thyroid carcinoma: where to set the limits?

      ea0026p485
    • mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures

      ea0026p486
    • Synchronous thyroid and gastric diffuse large B cell lymphoma

      ea0026p487
    • Radiodine therapy and age at menopause in women with differentiated thyroid cancer

      ea0026p488
    • Value of sonographic index point and resistivity index in the diagnosis of the malignant potential of nodular thyroid disease

      ea0026p489
    • Retrospective analysis of predictive factors for recurrence during long term follow-up in papillary thyroid cancer patients who had remission after primary treatment

      ea0026p490
    • Factors connected with the female sex - association with differentiated thyroid cancer

      ea0026p491
  • Bone/calcium/Vitamin D
  • • Does vitamin D replacement therapy improve insulin sensitivity in elderly?

      ea0026p492
    • Increased circulating levels of FGF23 an adaptive response in primary hyperparathyroidism?

      ea0026p493
    • Effects of ibandronate versus risedronate on hip bone density in the osteoporotic elderly

      ea0026p494
    • Overweight and risk for osteoporosis

      ea0026p495
    • Hip and lumbar spine BMD in overweight postmenopausal women

      ea0026p496
    • Incidence of osteoporosis study in premature ovarian failure

      ea0026p497
    • Bone markers of osteoblast/osteoclast activity in postmenopausal osteoporosis

      ea0026p498
    • Osteoporosis in the women with metabolic syndrome

      ea0026p499
    • Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density

      ea0026p500
    • Vitamin D deficiency in Spain: a population-based cohort study

      ea0026p501
    • Serum testosterone and estradiol in relation to bone mineral density, muscle strength and body composition in elderly men

      ea0026p502
    • Differential gene expression in Runx2 and osterix double heterozygotes during skeletal development

      ea0026p503
    • Sex-specific response of mammalian bone in vivo and in vitro to estrogens and to androgens

      ea0026p504
    • Insulin sensitivity and bone mineral density in primary hyperparathyroidism

      ea0026p505
    • Suspected parathyroid lesions and incidentally detected parathyroid adenomas during thyroid ultrasonography

      ea0026p506
    • Challenges and pitfalls in the management of persistent hyperparathyroidism: a case series

      ea0026p507
    • The diseases which are associated with asymptomatic primary hyperparathyroidism as an aid and obstacle for early diagnosis of the disease, especially arterial hypertension and malignancy

      ea0026p508
    • DT56a (Femarelle), contrary to estradiol-17[beta], has a positive stimulatory effect on human derived female cultured bone cells in hyperglycemic conditions

      ea0026p509
    • Calcium homeostasis in diabetic postmenopausal women with bone fracture

      ea0026p510
    • Vitamin D in Southern Italy multiple sclerosis patients

      ea0026p511
    • rs219780 SNP of CLDN14 gene is not associated with kidney stones, fractures or bone mineral density in primary hyperparathyroidism

      ea0026p512
    • Influence of thyroid disease in diagnostic accuracy of Tc99m-sestamibi scintigraphy in patients with primary hyperparathyroidism (PHP)

      ea0026p513
    • Secondary hyperparathyroidism in a patient with multiple myeloma

      ea0026p514
    • Bone mineral density and its contributing factors in type 1 diabetic patients

      ea0026p515
    • Hungry bone syndrome following parathyroidectomy

      ea0026p516
    • Genome-wide association in the Rotterdam study implicates the 16q24 locus as determinant of osteoporotic vertebral fractures

      ea0026p517
    • Bone turnover markers and the metabolic syndrome

      ea0026p518
    • Trace elements and bone mineral density in pre- and postmenopausal women

      ea0026p519
    • Fahr's syndrome in a patient with unknown hypoparathyroidism

      ea0026p520
    • Antagonism between body weight and adipocytokines on bone mass acquisition in pre- and postmenopausal women

      ea0026p521
    • Relationship between benign calcification of breast and lumbar bone mineral density

      ea0026p522
    • Vitamin D and bone metabolism in adult patients with cystic fibrosis

      ea0026p523
    • Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women

      ea0026p524
    • Efficacy of Alendronate treatment in women with postmenopausal osteoporosis: results after 3-year study

      ea0026p525
    • Bisphosponates therapy in women with post-menopausal osteoporosis: comparative results

      ea0026p526
    • Experience with Cinacalcet in primary hyperparathyroidism: results from the Swiss primary hyperparathyroidism cohort study

      ea0026p527
    • Diabetes mellitus and the incidence of fracture

      ea0026p528
    • The postprandial response of bone turnover in [beta]-thalassemia major

      ea0026p529
    • Recent changes in clinical presentation and therapeutic approach of primary hyperparathyroidism in MEN1 patients

      ea0026p530
    • Restitution of sever bone changes after succsessful treatment of primary hyperparathyroidism

      ea0026p531
    • Intrathymic localisation of parathyroid adenoma: case report

      ea0026p532
    • Thyroid gland disfunction and osteoporosis in elderly people

      ea0026p533
    • Dietary fructose inhibits lactation-induced adaptations in rat calcitriol synthesis and calcium transport

      ea0026p534
    • Prevalence of metabolic bone disease in Wilson's disease (WD) patients

      ea0026p535
    • Total parathyroidectomy without autotransplantation in the surgical treatment of 'refractory' renal hyperparathyroidism

      ea0026p536
    • The efficacy of four monthly 200 000 IU vitamin D3 supplementation to treat vitamin D deficiency in institutionalized elderly

      ea0026p537
    • Recurrent primary hyperparathyroidsim

      ea0026p538
    • Vitamin D and dark skin

      ea0026p539
    • Comparison of oral versus intramuscular treatment of vitamin D deficiency or insufficiency

      ea0026p540
    • Outcomes of parathyroidectomy with autotransplantation in nephrogenic secondary hyperparathyroidism

      ea0026p541
    • Pseudohypoparathyroidism and GNAS epigenetic alterations: quantitative analysis of methylation defects and correlation with clinical characteristics

      ea0026p542
    • Does total parathyroidectomy with autotransplantion simplify reinterventions for persistent or recurrent secondary hyperparathyroidism?

      ea0026p543
    • Bone turnover markers and vitamin D status over a training year in female elite alpine skiers

      ea0026p544
    • Some epidemiological aspects of primary hyperparathyroidism in Russia

      ea0026p545
    • Conservative therapy by cinacalcet for primary hyperparathyroidism management: first results of two center prospective study

      ea0026p546
    • The QUS fracture risk groups: unifactorial analyze regarding bone markers and DXA assessment

      ea0026p547
    • Bone density in patients with ACTH-dependent and ACTH-independent Cushing syndrome

      ea0026p548
    • Effects of atorvastatin and rosuvastatin therapy on serum 25-hydroxyvitamin D levels: a comparative study

      ea0026p548.1
  • Cardiovascular endocrinology and lipid metabolism
  • • Hashimoto's disease presenting as cardiac tamponade

      ea0026p549
    • The relation between metabolic syndrome and cognitive decline in elderly Turkish people

      ea0026p550
    • Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndrome

      ea0026p551
    • Inflammation indices and insulin resistance in metabolic syndrome with and without coronary artery disease

      ea0026p552
    • Regulation of fuel metabolism during exercise in hypopituitarism with growth hormone-deficiency (GHD)

      ea0026p553
    • Prevalence of androgen deficiency in males with metabolic syndrome: relation between hormonal and metabolic parameters

      ea0026p554
    • Polycystic ovary syndrome and their relationship with metabolic syndrome in female-to-male transsexuals

      ea0026p555
    • Is metabolic syndrome a useless category in subjects with high cardiovascular risk? Results from a cohort study in men with erectile dysfunction

      ea0026p556
    • Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction

      ea0026p557
    • Body mass index regulates hypogonadism-associated CV risk: results from a cohort of subjects with erectile dysfunction

      ea0026p558
    • Severe depressive symptoms and cardiovascular risk in subjects with erectile dysfunction

      ea0026p559
    • Priapus is happier with Venus than with Bacchus

      ea0026p560
    • Young women with the polycystic ovary syndrome (PCOS) have evidence of endothelial dysfunction but not of altered arterial structure

      ea0026p561
    • Metabolic syndrome and the effect of testosteron treatment in young men with congenital hypogonadotrophic hypogonadism

      ea0026p562
    • Determinants and outcome of amiodarone-associated thyroid dysfunction

      ea0026p563
    • Abstract unavailable

      ea0026p564
    • C-reactive protein and fibrinogen are strong predictors of the cardiovascular outcome in subjects with subclinical atherosclerosis and the metabolic syndrome

      ea0026p565
    • Apolipoprotein A1 and B100 and hormones in postmenopausal women

      ea0026p566
    • Cortisol secretion and HPA axis activity in patients undergoing coronary angiography

      ea0026p567
    • Plasma levels of the neurohormones A and B-type natriuretic peptides increases after weight loss in severe obesity

      ea0026p568
    • [alpha]-Defensins are novel biomarkers of low grade inflammation with strong prognostic impact in patients with heart failure

      ea0026p569
    • B-type natriuretic peptide modulates the response to intravenous glucose in a placebo-controlled cross-over study in healthy volunteers

      ea0026p570
    • D-Lys-GHRP-6, an antagonist of ghrelin receptor type 1a, did not antagonize the effect of acylated ghrelin but antagonized the effect of unacylated ghrelin on the growth of HECa10 murine endothelial cell line

      ea0026p571
    • Phosphate levels inversely correlate with aortic stiffness in patients with primary hyperparathyroidism

      ea0026p572
    • Low sex hormone binding globulin - strong association with metabolic syndrome in patients with acute coronary syndrome

      ea0026p573
    • Thyroid and parathyroids' dysfunction in patients suffering from chronic renal failure

      ea0026p574
    • Possible association between polyunsaturated fatty acids and parameters of metabolic syndrome in type 2 diabetes mellitus-pilot study

      ea0026p575
    • Parathormone 1-84 in type 2 diabetic patients

      ea0026p576
    • Rhabdomyolysis associated with fenofibrate: a case report

      ea0026p577
    • Utility of brain natriuretic peptide (BNP) as a biomarker of risk assessment in acute pulmonary embolism

      ea0026p578
    • Correlation of atherogenic dyslipidemia with other plaque instability biomarkers and outcome in non ST-segment elevation acute coronary syndromes (NSTE-ACS)

      ea0026p579
    • Relationship between plasma aldosterone concentration and soluble cellular adhesion molecules in patients referred to coronary angiography

      ea0026p580
    • Long term recreational physical exercise decreases angina susceptibility and induces cardiovascular protective shifts in nitric oxide synthase, heme oxygenase and matrix metalloproteinase enzyme regulation in rats

      ea0026p581
    • Heme-oxigenase mediates cardiovascular protection by oestrogen and raloxifene in menopause

      ea0026p582
  • Clinical case reports
  • • MGMT immunoexpression in adamantinomatous craniopharyngiomas

      ea0026p583
    • Tolvaptan versus conventional treatment in hyponatraemia secondary to syndrome of inappropriate anti-diuretic hormone (SIADH): first case experience in West-Midlands region, UK

      ea0026p584
    • Coexistence of double small insulinomas with a small glucagonoma in a patient with multiple endocrine neoplasia-type 1 (MEN-1)

      ea0026p585
    • A case report of macronodular adrenal hyperplasia with combined cortisol and aldosterone oversecretion in response to [beta]-adrenergic and vasopressin stimuli

      ea0026p586
    • Virilizing ovarian tumor - case report

      ea0026p587
    • Congenital adrenal hyperplasia and adrenal myelolipoma - incidental ou causal relationship?

      ea0026p588
    • Agenesis of the dorsal pancreas, a rare cause of diabetes: a case report and review of 25 Japanese patients

      ea0026p589
    • A case of two novel mutations in the LHCGR gene in a patient with 46,XY DSD

      ea0026p590
    • X-linked adrenomieloneuropathy presenting as Addison's disease

      ea0026p591
    • Central precocious puberty related to a tuber cinereum hamartoma in neurofibromatosis type 1 (NF1): case report

      ea0026p592
    • Hypoparathyroidism and Morbus Fahr case report

      ea0026p593
    • Acute respiratory distress syndrome in a nonsurgical transsexual

      ea0026p594
    • A unique case of multifocal intrathyroid parathyroid carcinoma

      ea0026p595
    • Conservative or radical approach in patients with 46 XY disorders of sex development?

      ea0026p596
    • Use of our last pills of iopanoic acid in a 33-year-old patient in acute refractory pulmonary edema and thyroid storm: requiem for a useful therapeutic agent

      ea0026p597
    • Hypocalcemic laryngospasm in the emergency department

      ea0026p598
    • Thyroid storm in the emergency department

      ea0026p599
    • Lady with backache and inadequate work-up for hypercalcemia for 5 years

      ea0026p600
    • Primary hyperparathyroidism due to an ectopic intrathymic parathyroid adenoma: case report

      ea0026p601
    • Clinical case of 48 years old man with panhypopituitarism of unclear etiology

      ea0026p602
    • Unusual case of congenital adrenal hyperplasia: polymenorrhagia and markedly high 17-OH progesterone levels in a lady with non classic congenital adrenal hyperplasia

      ea0026p603
    • Schmidt's syndrome: unveiling step-by-step

      ea0026p604
    • Primary hyperparathyroidism in pregnancy: a case report

      ea0026p605
    • Primary hypothyroidism due to sublingual thyroid associated with growth failure, hyperprolactinemia and pituitary enlargement

      ea0026p606
    • Hypoglycemia in patient with large intraabdominal tumor

      ea0026p607
    • Pheochromocytoma and paraganglioma in patient with extirpated ganglioneuroma

      ea0026p608
    • Cushing syndrome due to macronodular adrenal hyperplasia or bilateral adrenocortical adenomas? Case report

      ea0026p609
    • Cholestatic jaundice methimazole-induced or secondary to heart failure?

      ea0026p610
    • Remind familial hypocalciuric hypercalcemia as a cause of elevated parathyroid hormone and serum calcium: 5 patients

      ea0026p611
    • Iatrogenic hypoadrenalism: a case report

      ea0026p612
    • Diabetes insipidus in the context of sarcoidosis: a case report

      ea0026p613
    • A case of small cell lung cancer of which first finding is hyponatremia

      ea0026p614
    • Evaluation of autoimmune endocrine disturbances in celiac patients

      ea0026p615
    • Autoimmune polyglandular endocrinopathy associated with collagenous sprue: a case report

      ea0026p616
    • Iatrogenic lymphocytic hypophysitis

      ea0026p617
    • A rare cause of nontraumatic rhabdomyolysis: central diabetes insipidus

      ea0026p618
    • Our clinical experience in percutenous ethanol injection into cystic tyroid nodules

      ea0026p619
    • Two cases of allergic reactions which has developed due to usage of insulin analogues

      ea0026p620
    • Sheehan's syndrome primary presenting as central diabetes insipidus: case report

      ea0026p621
    • Hepatic metastasis of parathyroid carcinoma: case report

      ea0026p622
    • IGF2 producing prostate tumour causing severe hypoglycaemia: case report

      ea0026p623
    • 17[beta]-hydroxysteroid dehydrogenase type 3 deficiency: a new case of a rare disease with an uncommon gene mutation

      ea0026p624
    • Testicular microlithisis: how worried should we be?

      ea0026p625
    • Virilizing ovarian steroid cell tumor: clinical case

      ea0026p626
    • Clinical, hormonal and cytogenetic evaluation of 46,XX male

      ea0026p627
    • Five year follow-up of recurrent parathyroid carcinoma in a young man: a case report

      ea0026p628
    • Unexpected association: Turner syndrome and hypopituitarism: a case report

      ea0026p629
    • A rare variant of Wolfram syndrome with diabetic microvascular disease, hypergonadotropic hypogonadism and palmar fibromatosis: case report

      ea0026p630
    • 'Uterine neuroendocrine tumour: an unusual cause of hyponatraemia' and the role of tolvaptan, a vasopressin V2 receptor antagonist

      ea0026p631
    • Diagnosis of Bruns-Garland syndrome in a patient with McArdle disease and type 2 diabetes mellitus

      ea0026p632
    • Lower limb Merkel cell carcinoma with a single metastasis in a thyroid nodule

      ea0026p633
    • An old story again with a new patient in modern world: acute adrenal insufficiency in a 51-year old man with vertebral tuberculosis

      ea0026p634
    • A case of a parathyroid adenoma with Celiac disease: primary or quaternary hyperparathyroidism?

      ea0026p635
    • A case of congenital adrenal hyperplasia of 11[beta]-hydroxylase deficiency presented with Addisonian crisis

      ea0026p636
    • Diabetes and A1C. How a hemoglobin variant affect A1C test: a case report

      ea0026p637
    • Hyponatremic coma with seizures as onset of isolated ACTH deficiency

      ea0026p638
    • GH in Prader-Willi syndrome: to treat or not to treat

      ea0026p639
    • Subacute onset in severe Riedel thyroiditis associated with hypoparathyroidism and left recurrent palsy

      ea0026p640
    • Multiple pituitary deficiencies in a young patient with primary empty sella

      ea0026p641
    • Giant invasive macroprolactinoma

      ea0026p642
    • Bexarotene associated dyslipidaemia and central hypothyroidism in a patient with Sezary syndrome

      ea0026p643
    • Diffuse nodular hyperplasia of the adrenal cortex in a patient with renal cysts

      ea0026p644
    • A case of polymyositis and vasculitis induced by ovulation induction therapy with GnRH: case report

      ea0026p645
    • Diabetes insipidus in a patient with breast carcinoma

      ea0026p646
    • Ovarian hyperthecosis with type 2 diabetes mellitus and severe insulin resistance in postmenopausal woman

      ea0026p647
    • How differentiated can a poorly differentiated thyroid cancer be? A rare case presenting with hyperthyroidism and secondary adrenal insufficiency

      ea0026p648
    • HDR syndrome or Barakat syndrome

      ea0026p649
    • Coincidental presence of acromegaly and nonclassical congenital adrenal hyperplasia in a patient with hirsutism: a case report

      ea0026p650
    • Adrenal rest in a patient with late onset 21-hydroxylase deficiency

      ea0026p651
    • Long term evolution of a coincident ACTH-dependent and independent Cushing's syndrome

      ea0026p652
    • Maltose interference in the determination of blood glucose levels by test strips based on glucose dehydrogenase-PQQ method: a case report

      ea0026p653
    • Type II polyglandular syndrome: a case report

      ea0026p654
    • Impact of two novel mutations of calcium sensing receptor (CaSR) gene on calcium metabolism: two clinical case reports

      ea0026p655
  • Developmental endocrinology
  • • Comparative levels of serum/plasma concentrations of hormones in Juvenile periodontitis patients of Pakistan

      ea0026p656
    • Zilpaterol hydrochloride (a [beta]-agonist) improve growth performance and carcass quality in castrated goat

      ea0026p657
    • Disorders of sex development: current scenario in North East India

      ea0026p658
    • Cost-effectiveness analysis of conservative treatment strategy in patients with diabetic foot in Moscow

      ea0026p659
  • Diabetes therapy
  • • Method of myocardial preconditioning during exercise tests in patients with type 2 diabetes mellitus after acute myocardial infarction

      ea0026p660
    • Effect of amino acid residues on N-terminal extension of GLP-1/IgG-Fc fusion protein

      ea0026p661
    • Evaluation of the global impact of incorporating a telemedicine system for type 1 diabetes patients with an insulin pump and real-time continuous glucose monitoring system

      ea0026p662
    • Evaluation of adolescents type 1 diabetic patients after transition from paediatric to adult care

      ea0026p663
    • Clinical effectiveness of a bolus calculator in patients with type 1 diabetes mellitus treated with insulin pump

      ea0026p664
    • Evaluation of long term outcomes of intensive treatment with s.c. insulin infusion (CSII) in type 1 diabetic patients

      ea0026p665
    • Experience with the use of a real time continuous glucose monitoring system during the simultaneous pancreas kidney transplant in patients with diabetes

      ea0026p666
    • Unacylated ghrelin improves insulin sensitivity in the early phase of obesity

      ea0026p667
    • Antihyperglycemic action of creatine compared to glibenclamide in type II diabetic patients

      ea0026p668
    • Impact of a DPP4-inhibitor on liver and heart lipid content and cardiovascular risc in type 2 diabetic patients

      ea0026p669
    • Self-monitoring of blood glucose in type 2 diabetes mellitus: effect on glycemic control in non-insulin-treated patients

      ea0026p670
    • Insulin resistance of multiple metabolic pathways in patients with type 1 diabetes on long term continuous s.c. insulin infusion therapy

      ea0026p671
    • Factors related with the adherence of physicians to diabetes guidelines in type 2 DM patients in Turkey

      ea0026p672
    • Effects of estradiol+drospirenone on sexual function in postmenopausal women with type 2 diabetes mellitus

      ea0026p673
    • Effect of sitagliptin monotherapy on serum total ghrelin levels in type 2 diabetic patients

      ea0026p674
    • UK National Exenatide Guidelines (NICE:CG87) compared to clinical outcomes at a district general hospital's diabetes department

      ea0026p675
    • Remission of diabetic nephropathy in type 2 diabetic Asian population: role of tight glucose and blood pressure control

      ea0026p676
    • Comparative study of combination therapy between metformin plus thiazolinedione (TZD) and metformin plus DPP-4 inhibitor in type 2 diabetes

      ea0026p677
    • Insulin analogue management: subjective and objective assessment of life quality in patients previously managed with human insulin

      ea0026p678
    • Twelve months exenatide treament in type 2 diabetes and severe obesity

      ea0026p679
    • New opportunity of treatment women with postmenopausal osteoporosis and diabetes mellitus type 2

      ea0026p680
    • Effects of lifestyle changes on incidents of type II diabetes in Tehran adult population

      ea0026p681
    • The addition of acipimox in patients with type 2 diabetes with triglyceride level over 150 mg/dl in spite of fenofibrate therapy

      ea0026p682
    • Monitoring thyroid function in diabetic patients on treatment with glucagon-like peptide 1 analog

      ea0026p683
    • Impact of structured testing on level of glycemic control

      ea0026p684
    • Insulin therapy of diabetes mellitus type 2 and risk of development cardiovascular mortality

      ea0026p685
  • Diabetes complications
  • • Diabetic retinopathy in type 1 diabetes mellitus patients with depression

      ea0026p686
    • The frequency distribution of PPAR[gamma]2 Pro12Ala polymorphism in type 2 diabetic, cardiac patients and healthy subjects of Bangladeshi population

      ea0026p687
    • The risk factors for cardiovascular disease in type 2 diabetes patients

      ea0026p688
    • Study of endothelial dysfunction in diabetes. assesment of ANP leves in patients without vascular disease

      ea0026p689
    • Obese diabetics and left ventricular hypertrophy

      ea0026p690
    • Psychoemotional status and quality of life of T1DM patients

      ea0026p691
    • Features of the lipid exchange among the patients suffering from diabetes with various degree of carbohydrate exchange compensation

      ea0026p692
    • Diabetic foot with risk for ulceration associated with diabetic retinopathy in type 2 diabetes

      ea0026p693
    • Type 2 diabetes mellitus and testosterone: a meta-analysis study

      ea0026p694
    • Early diagnostics of diabetic peripheral neuropathy manifestations in patients with diabetes mellitus

      ea0026p695
    • Changes in GLUT1 expression under metformin treatment in rat models of severe and mild stretozotocin diabetes mellitus

      ea0026p696
    • The study of DM late complications prevalence and risk factors contributing to their progression in urban and rural diabetics of Uzbekistan

      ea0026p697
    • Illuminating diabetic neuropathy: novel systems for in vivo monitoring and microenvironmental investigations in a murine model

      ea0026p698
    • Gilbert syndrome and diabetes: a perfect union?

      ea0026p699
    • Influence of metabolic disorders in children with diabetes mellitus type 1 on changes of QT interval

      ea0026p700
    • Receptor activator of nuclear factor kappa [beta] ligand and osteoprotegerin levels in the patients with diabetic nephropathy

      ea0026p701
    • Matrix [gamma]-carboxyglutamate (Gla) protein (MGP) in type 2 diabetes

      ea0026p702
    • Diabetic patients with autonomic neuropathy do need erythropoetin therapy at the early stagies of renal failure

      ea0026p703
    • Beta estrogen receptors inhibition improves wound healing in diabetes

      ea0026p704
    • Diabetes mellitus and risk of fracture

      ea0026p705
    • Health illiteracy as a challenge in contemporary endocrinology

      ea0026p706
    • Adrenocortical hypofunction in patients with diabetes mellitus type 1

      ea0026p707
    • Effect of oxytocin on the blood glucose level in rat

      ea0026p708
  • Diabetes (epidemiology, pathophysiology)
  • • To develop non-invasive cytochemical diagnostic technique and monitoring of compensation of diabetes mellitus type 2

      ea0026p709
    • Continuous glucose monitoring enhances the diagnostic value of mixed meal test in reactive hypoglycemia

      ea0026p710
    • Vitamin D and gestational diabetes

      ea0026p711
    • The frequency of Cushing's disease among obese, type 2 diabetes mellitus patients: a single center experience in Turkey

      ea0026p712
    • Resting energy expenditure in impaired glucose metabolism

      ea0026p713
    • A rare case: Shwachman-Diamond syndrome presenting with diabetic ketoacidosis

      ea0026p714
    • Autoimmune markers in patients with type 1 diabetes mellitus

      ea0026p715
    • Prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes

      ea0026p716
    • The fed to fasting transition differentially affects PEPCK protein expression in pericentral and periportal murine hepatocytes

      ea0026p717
    • Disturbed subjective sleep characteristics in adult patients with type 1 diabetes mellitus

      ea0026p718
    • Prevalence of depressive syndrome in type 2 diabetes. Sociodemographic, clinical and biochemical differences

      ea0026p719
    • Diagnostic criteria for glucose homeostasis abnormalities in obese patients: are there any differences?

      ea0026p720
    • Glycated hemoglobin as diagnostic criteria for diabetes and prediabetes in obese patients

      ea0026p721
    • Impact of INSR His1085 and IRS1 Gly972Arg genetic variability on dyslipidaemia in patients with metabolic syndrome and type 2 diabetes

      ea0026p722
    • High prevalence of impaired glucose metabolism in young adult patients with Williams syndrome

      ea0026p723
    • TCF7L2 gene variants and plasma C-peptide concentrations in diabetes type 2

      ea0026p724
    • Risk factors of conversion from IGT and IFG to diabetes type 2

      ea0026p725
    • Effects of the ghrelin gene products on glucose metabolism in C2C12 muscle cells

      ea0026p726
    • Effects of Ramadan fasting on resting energy expenditure in T2DM

      ea0026p727
    • Chronic supplementation of [beta]-hydroxy-[beta] methylbutyrate (HM[beta]) impairs glucose homeostasis in rats under normal conditions

      ea0026p728
    • Serum levels of fetuin-A correlate with bone turnover biomarkers in patients with type 2 diabetes mellitus

      ea0026p729
    • The stress influence on the diabetes mellitus occurrence in the territory of northern Kosovo and Metohija in the period of 2000-2002

      ea0026p730
    • Prevalence of a gestational diabetes and it's risk factors estimation

      ea0026p731
    • Relationship between diabetes and pancreatic cancer

      ea0026p732
    • Vaspin circulating levels in severely obese women with type 2 diabetes mellitus (T2DM): early changes following restrictive bariatric surgery

      ea0026p733
    • Does anxiety influence food preference and insulin resistance in healthy men?

      ea0026p734
    • Insulin restores salivary secretion in diabetic rats: involvement of Na+/glucose cotransporter SGLT1

      ea0026p735
    • The prevalence of diabetes mellitus in patients infected with human immunodeficiency virus on treatment with antiretoviral drugs

      ea0026p736
    • Linking CERN and TERM: testing the acceleration hypothesis

      ea0026p737
    • Metabolic syndrome in normotensive non diabetic population in Jeddah: a pilot study

      ea0026p738
    • Cost of treating diabetes in a developing economy

      ea0026p739
    • Comparison of the diagnostic criteria for PreDiabetes on a overweight population

      ea0026p740